No Data
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Silence Therapeutics (SLN) and Exscientia Plc (EXAI)
Exscientia Acquires Oral CDK7 Inhibitor for $20m, Plans Breast Cancer Trial
Exscientia to Acquire Full Rights to Lead Asset
Exscientia Shares Down On Unchanged Cash Runway Expectations After Acquisition
Exscientia to Acquire Full Control of Cancer Drug Program From GT Apeiron
Exscientia Secures Full Rights to Novel Cancer Drug